Phreesia (PHR) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
30 Jun, 2026Opening remarks and agenda
The meeting was called to order by the CEO, who welcomed stockholders and visitors and outlined the agenda and rules of conduct for the virtual meeting.
Directors, officers, independent auditors, and outside counsel were introduced at the start.
The meeting was held in accordance with company bylaws and Delaware law, with formal business as described in the notice and proxy statement.
Board and executive committee updates
The board consists of nine directors, and key officers were introduced, including the CFO and presidents of Provider and Network Solutions.
The independent auditor (KPMG LLP) and outside counsel (Goodwin Procter LLP) were present.
Shareholder proposals
Three proposals were presented: election of two Class I directors for a three-year term, ratification of KPMG as independent auditor for FY ending January 31, 2027, and a non-binding advisory vote on executive compensation for FY 2026.
No stockholder nominations for directors were received.
Latest events from Phreesia
- Q1 FY2027 revenue up 13%, net income $3M, and FY2027 guidance reaffirmed.PHR
Q1 202728 May 2026 - Proxy seeks approval for director elections, auditor ratification, and executive pay, highlighting governance and ESG.PHR
Proxy filing14 May 2026 - Key votes include director elections, auditor ratification, and executive pay approval.PHR
Proxy filing14 May 2026 - FY27 revenue guidance lowered on pharma headwinds, but margin and cash flow outlooks remain strong.PHR
Q4 202630 Mar 2026 - 19% revenue growth, positive free cash flow, and improved EBITDA mark a strong Q2 FY25.PHR
Q2 202522 Jan 2026 - Revenue up 17%, net loss narrowed, and Adjusted EBITDA positive with strong outlooks ahead.PHR
Q3 202511 Jan 2026 - Double-digit revenue growth, positive cash flow, and strong 2026 outlook maintained.PHR
Q4 202526 Dec 2025 - Q3 FY2026 saw 13% revenue growth, profitability, and a major acquisition completed.PHR
Q3 20269 Dec 2025 - Annual meeting to vote on directors, auditor, and executive pay, with focus on governance and ESG.PHR
Proxy Filing1 Dec 2025